Medline director Galanti awarded 5,387 RSUs
GALANTI RICHARD A reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
GALANTI RICHARD A reported acquisition or exercise transactions in this Form 4 filing.
Medline Inc. director Richard A. Galanti reported stock-based compensation awards rather than open‑market purchases. He received 5,387 shares of Class A Common Stock as a grant at a price of $0.00 per share, bringing his direct holdings to 16,392 shares. Footnotes explain these are restricted stock units that vest either on March 30, 2027 or on the earlier of the first anniversary of grant and the next annual meeting of stockholders.
Insider Trade Summary
Grant/Award: 16,392 shares
Grant/Award
2 txns
Insider
GALANTI RICHARD A
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock | 5,387 | $0.00 | $0.00 |
| Grant/Award | Class A Common Stock | 11,005 | $0.00 | $0.00 |
Holdings After Transaction:
Class A Common Stock — 16,392 shares (Direct)
Footnotes (2)
- F1. These securities were acquired in connection with the reclassification of the interests of Medline Holdings, LP prior to the Issuer's initial public offering (as more fully described in the Registration Statement on Form S-1). These securities were previously reported on the Reporting Person's Form 3 filed on December 17, 2025. Represents a grant of restricted stock units ("RSUs") that vest on March 30, 2027.
- F2. Represents a grant of RSUs that vest on the earlier of (i) the first anniversary of the date of grant, and (ii) the next annual meeting of stockholders following the date of grant.
Key Figures
Latest RSU grant: 5,387 shares
Prior RSU grant: 11,005 shares
Price per share for grants: $0.00 per share
+3 more
6 metrics
Latest RSU grant
5,387 shares
Class A Common Stock grant on June 11, 2026
Prior RSU grant
11,005 shares
Class A Common Stock grant on December 16, 2025
Price per share for grants
$0.00 per share
Both grants recorded as awards with no cash paid
Shares held after latest grant
16,392 shares
Total direct Class A Common Stock holdings following June 11, 2026 award
RSU vesting date
March 30, 2027
One RSU grant vests fully on this date
Alternative vesting trigger
Earlier of first anniversary or next annual meeting
Vesting condition for a separate RSU grant
Key Terms
restricted stock units ("RSUs"), initial public offering, Registration Statement on Form S-1, annual meeting of stockholders
4 terms
restricted stock units ("RSUs") financial
"Represents a grant of restricted stock units ("RSUs") that vest on March 30, 2027."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
initial public offering financial
"reclassification of the interests of Medline Holdings, LP prior to the Issuer's initial public offering"
An initial public offering (IPO) is when a private company first sells its shares to the public and becomes a stock-listed company. It matters because it allows the company to raise money from a wide range of investors, helping it grow, while giving early shareholders a way to sell some of their ownership.
Registration Statement on Form S-1 regulatory
"as more fully described in the Registration Statement on Form S-1"
A registration statement on Form S-1 is a detailed filing a company submits to the U.S. securities regulator to register new shares for public sale; it includes a plain-language prospectus, financial statements, business description and risk factors. For investors it matters because it provides the official, comprehensive blueprint of the offering — like an owner’s manual — allowing buyers to assess risks, inspect financial health and compare valuation before deciding to invest.
annual meeting of stockholders financial
"vest on the earlier of (i) the first anniversary of the date of grant, and (ii) the next annual meeting of stockholders"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Medline (MDLN) director Richard A. Galanti report in this Form 4?
Richard A. Galanti reported receiving a grant of 5,387 shares of Medline Class A Common Stock as stock-based compensation. The award was recorded at a price of $0.00 per share and increased his directly held position to a total of 16,392 shares.
What vesting terms apply to the Medline (MDLN) RSU grants in this filing?
The filing notes restricted stock units that vest on March 30, 2027 and another grant that vests on the earlier of the first anniversary of the grant date or the next Medline annual stockholder meeting. Vesting schedules affect when the director fully receives the underlying shares.
What earlier Medline (MDLN) grant is referenced in Richard A. Galanti’s Form 4?
One footnote explains that certain securities were acquired in connection with a reclassification of Medline Holdings, LP interests before Medline’s initial public offering. These securities were previously reported on Galanti’s Form 3 filed on December 17, 2025 as restricted stock units.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates